Marc Gunter

Marc Gunter has made significant contributions to understanding how obesity-related hormonal changes including elevated estrogens, insulin, and inflammatory mediators promote cancer development in non-reproductive organs, using large-scale metabolomics and biomarker studies within the EPIC cohort. His research at IARC has demonstrated that circulating metabolic and hormonal profiles can identify individuals at elevated cancer risk across multiple organ systems, informing precision prevention strategies. His work integrates metabolomics, endocrinology, and cancer epidemiology to define the hormonal mechanisms linking obesity to cancer risk.